Sirolimus-Eluting Stents Remain Superior to Bare-Metal Stents at Two Years: Medium-Term Results From the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) Registry
Andrew T.L. Ong, Ron T. van Domburg, Jiro Aoki, Karel Sonnenschein, Pedro A. Lemos, Patrick W. SerruysVolume:
47
Year:
2006
Language:
english
DOI:
10.1016/j.jacc.2005.05.102
File:
PDF, 128 KB
english, 2006